During the study period, experts independently identified the number of patients treated in the CTIC for prioritized tumors: 13 patients with advanced gastric cancer, 21 with non‐driver non‐small cell lung cancer (NSCLC), 11 with epidermal growth factor receptor (EFGR) NSCLC, and 32 with multiple myeloma. This evidence concerns the gene EGFR and AL amyloidosis.